Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: Diagnostic and therapeutic impact of assay performance

European Journal of Clinical Investigation

Volumn 32, Issue 12, 2002, Pages 931-937

  Christ Crain, M ^a   Meier, C ^a   Roth, C B ^a   Huber, P ^a   Staub, J J ^a   Muller B ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Hyperthyroidism; Thyroid function tests; Thyrotropin

Indexed keywords

PROTIRELIN; RELEFACT; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID FUNCTION TEST; TITRIMETRY;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; AGED; FEMALE; HUMANS; HYPERTHYROIDISM; IMMUNOASSAY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THYROID FUNCTION TESTS; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 0036460010     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01065.x     Document Type: Article

References (28)

1. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med 2001;345:512-6.
2. Utiger RD. Subclinical hyperthyroidism - Just a low serum thyrotropin concentration, or something more? N Engl J Med 1994;331:1302-3.
3. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T et al. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 2000;85:4157-61.
4. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2000;134:561-8.
5. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: A metaanalysis. J Clin Endocrinol Metab 1996;81:4278-89.
6. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
7. Munte TF, Radamm C, Johannes S, Brabant G. Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: A double-blind cross-over study using event-related brain potentials. Thyroid 2001;11:385-91.
8. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000;53:733-7.
9. Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lambardi G et al. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1996;81:4224-8.
10. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet 2001;358:861-5.
11. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
12. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
13. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 1987;317:70-5.
14. Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Nicoloff JT. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 1993;76:494-8.
15. Seth J, Kellett HA, Caldwell G, Sweeting VM, Beckett GJ et al. A sensitive immunoradiometric assay for serum thyroid stimulating hormone: A replacement for the thyrotrophin releasing hormone test? Br Med J (Clin Res Ed) 1984;289:1334-6.
16. Duntas L, Grab BM, Dominguez-Munoz JE, Nelson DK, Loos U, Keck FS. Evaluation of thyrotropin secretion before and after TRH by third generation chemiluminescent assay. Assessment of subclinical hyperthyroidism. Horm Metab Res 1993;25:430-3.
17. Roden M, Nowotny P, Vierhapper H, Waldhäusl W. Diagnostic relevance of suppressed basal concentrations of TSH compared with the negative TRH test in detection and exclusion of hyperthyroidism. Acta Endocrinol (Copenh) 1991;124:136-42.
18. Staub JJ, Noelpp B, Gräni R, Gemsenjäger E, Hauenstein M, Girard J. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH releasing hormone in patients with preclinical hypothyroidism. J Clin Endocr 1983;56:449-53.
19. Staub JJ, Althaus B, Engler H, Ryff A, Trabucco P et al. The spectrum of subclinical and overt hypothyroidism on peripheral target tissues. Am J Med 1992;92:631-42.
20. Müller B, Zulewski H, Huber P, Ratcliffe JG, Staub JJ. Impaired action of thyroid hormone associated with smoking in women with subclinical hypothyroidism. N Engl J Med 1995;333:964-9.
21. Klee GG, Hay ID. Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: Proposed criteria for analytic performance and clinical utility. J Clin Endocrinol Metab 1987;64:461-71.
22. Caldwell G, Gow SM, Sweeting VM, Beckett GJ, Seth J, Toft AD. Value and limitations of a highly sensitive immunoradiometric assay for thyrotropin in the study of thyrotroph function. Clin Chem 1987;33:303-5.
23. Ross DS, Ardisson LJ, Meskell MJ. Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab 1989;69:684-8.
24. Faber J, Wiinberg N, Schifter S, Mehlen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 2001;145:391-6.
25. Keller H. Does the determination of basal TSH level replace the TRH test? Swiss Med Weekly 1986;116(30):1009-15.
26. Franklyn JA, Black EG, Betteridge J, Sheppard MC. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab 1994;78:1368-71.
27. Taimela E, Tahtela R, Koskinen P, Nuutila P, Forsstrom J et al. Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH. Clin Chem 1994;40:101-5.
28. Wilkinson E, Rae PW, Thomson KJ, Toft AD, Spencer CA, Beckett GJ. Chemiluminescent third-generation assay (Amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed. Clin Chem 1993;39:2167-73.